25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANIX (Anixa) Stock Analysis
Buy, Hold or Sell?

Let's analyze Anixa together

I guess you are interested in Anixa Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Anixa’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Anixa’s Price Targets

I'm going to help you getting a better view of Anixa Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anixa Biosciences Inc

I send you an email if I find something interesting about Anixa Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Anixa (30 sec.)










1.2. What can you expect buying and holding a share of Anixa? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.47
Expected worth in 1 year
$0.31
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-3.6%

For what price can you sell your share?

Current Price per Share
$4.47
Expected price per share
$4.0954 - $5.13
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anixa (5 min.)




Live pricePrice per Share (EOD)
$4.47
Intrinsic Value Per Share
$-1.94 - $-1.62
Total Value Per Share
$-1.48 - $-1.15

2.2. Growth of Anixa (5 min.)




Is Anixa growing?

Current yearPrevious yearGrowGrow %
How rich?$15.4m$22.5m-$6m-36.9%

How much money is Anixa making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$3m$311.5k11.2%
Net Profit Margin0.0%-431.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Anixa (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#505 / 844

Most Revenue
#796 / 844

Most Profit
#339 / 844

Most Efficient
#226 / 844
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anixa?

Welcome investor! Anixa's management wants to use your money to grow the business. In return you get a share of Anixa.

First you should know what it really means to hold a share of Anixa. And how you can make/lose money.

Speculation

The Price per Share of Anixa is $4.47. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anixa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anixa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.47. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anixa.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.07-1.5%-0.08-1.9%-0.09-2.1%-0.09-1.9%-0.09-2.0%-0.08-1.8%
Usd Book Value Change Per Share0.020.3%-0.04-0.9%-0.03-0.7%-0.04-0.9%0.010.2%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.020.3%-0.04-0.9%-0.03-0.7%-0.04-0.9%0.010.2%0.010.2%
Usd Price Per Share3.06-3.06-3.50-3.66-3.70-3.59-
Price to Earnings Ratio-11.15--9.22--9.32--10.78--10.57--9.95-
Price-to-Total Gains Ratio199.46-10.21-100.58-3.33--1.86--117.21-
Price to Book Ratio6.54-6.13-5.10-5.56-5.39-17.43-
Price-to-Total Gains Ratio199.46-10.21-100.58-3.33--1.86--117.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.47
Number of shares223
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.01
Usd Total Gains Per Share-0.040.01
Gains per Quarter (223 shares)-8.942.46
Gains per Year (223 shares)-35.779.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-36-460100
20-72-8202010
30-107-11803020
40-143-15403930
50-179-19004940
60-215-22605950
70-250-26206960
80-286-29807970
90-322-33408980
100-358-37009990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%5.0138.00.03.5%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%12.028.00.030.0%49.088.06.034.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%7.00.0136.04.9%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%12.028.00.030.0%49.088.06.034.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anixa Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.015-0.040+361%-0.030+293%-0.039+356%0.011+39%0.007+115%
Book Value Per Share--0.4680.501-6%0.685-32%0.663-29%0.739-37%0.438+7%
Current Ratio--8.4468.806-4%13.353-37%13.194-36%16.520-49%10.897-22%
Debt To Asset Ratio--0.1270.123+4%0.081+57%0.089+42%0.078+62%0.243-48%
Debt To Equity Ratio--0.1350.130+3%0.084+60%0.094+44%0.082+64%0.428-68%
Dividend Per Share----0%-0%-0%-0%0.000-100%
Enterprise Value--114514759.900115707552.188-1%136055910.213-16%140860185.850-19%145073474.543-21%131247294.418-13%
Eps---0.069-0.084+23%-0.094+37%-0.086+26%-0.090+31%-0.081+18%
Ev To Ebitda Ratio---11.752-9.802-17%-10.245-13%-11.660-1%-11.929+2%-15.029+28%
Free Cash Flow Per Share---0.046-0.052+13%-0.064+39%-0.053+16%-0.049+7%-0.041-10%
Free Cash Flow To Equity Per Share--0.013-0.037+388%-0.036+386%-0.040+414%0.058-78%0.031-59%
Gross Profit Margin--1.0001.0000%1.0020%1.0010%1.0000%1.0000%
Intrinsic Value_10Y_max---1.622----------
Intrinsic Value_10Y_min---1.945----------
Intrinsic Value_1Y_max---0.165----------
Intrinsic Value_1Y_min---0.211----------
Intrinsic Value_3Y_max---0.494----------
Intrinsic Value_3Y_min---0.625----------
Intrinsic Value_5Y_max---0.821----------
Intrinsic Value_5Y_min---1.023----------
Market Cap147138610.050+32%100725759.900100808052.1880%115126910.213-13%120366185.850-16%121776127.043-17%118138725.643-15%
Net Profit Margin----0%-4.3110%-2.2450%-0.7240%-0.6760%
Operating Margin----0%-4.3610%-2.4740%-0.8570%-0.7140%
Operating Ratio----0%4.909-100%2.736-100%1.019-100%0.841-100%
Pb Ratio9.548+32%6.5366.127+7%5.098+28%5.564+17%5.389+21%17.430-63%
Pe Ratio-16.291-46%-11.152-9.217-17%-9.317-16%-10.777-3%-10.572-5%-9.954-11%
Price Per Share4.470+32%3.0603.0630%3.498-13%3.657-16%3.700-17%3.589-15%
Price To Free Cash Flow Ratio-24.345-46%-16.665-17.807+7%-14.128-15%-19.734+18%-21.215+27%-25.675+54%
Price To Total Gains Ratio291.364+32%199.45710.211+1853%100.579+98%3.330+5889%-1.855+101%-117.213+159%
Quick Ratio--14.79315.637-5%24.747-40%23.279-36%24.209-39%15.697-6%
Return On Assets---0.128-0.149+16%-0.126-1%-0.121-5%-0.122-5%-0.223+75%
Return On Equity---0.136-0.158+16%-0.132-3%-0.127-7%-0.127-6%-0.291+114%
Total Gains Per Share--0.015-0.040+361%-0.030+293%-0.039+356%0.011+39%0.008+104%
Usd Book Value--15411000.00016479500.000-6%22561750.000-32%21814583.333-29%24317455.000-37%14417389.350+7%
Usd Book Value Change Per Share--0.015-0.040+361%-0.030+293%-0.039+356%0.011+39%0.007+115%
Usd Book Value Per Share--0.4680.501-6%0.685-32%0.663-29%0.739-37%0.438+7%
Usd Dividend Per Share----0%-0%-0%-0%0.000-100%
Usd Enterprise Value--114514759.900115707552.188-1%136055910.213-16%140860185.850-19%145073474.543-21%131247294.418-13%
Usd Eps---0.069-0.084+23%-0.094+37%-0.086+26%-0.090+31%-0.081+18%
Usd Free Cash Flow---1511000.000-1711250.000+13%-2094250.000+39%-1754583.333+16%-1623231.450+7%-1360104.750-10%
Usd Free Cash Flow Per Share---0.046-0.052+13%-0.064+39%-0.053+16%-0.049+7%-0.041-10%
Usd Free Cash Flow To Equity Per Share--0.013-0.037+388%-0.036+386%-0.040+414%0.058-78%0.031-59%
Usd Market Cap147138610.050+32%100725759.900100808052.1880%115126910.213-13%120366185.850-16%121776127.043-17%118138725.643-15%
Usd Price Per Share4.470+32%3.0603.0630%3.498-13%3.657-16%3.700-17%3.589-15%
Usd Profit---2258000.000-2778750.000+23%-3090250.000+37%-2794833.333+24%-2939471.750+30%-2588616.650+15%
Usd Revenue----0%39000.000-100%205780500.000-100%123668382.000-100%61599825.550-100%
Usd Total Gains Per Share--0.015-0.040+361%-0.030+293%-0.039+356%0.011+39%0.008+104%
 EOD+6 -2MRQTTM+17 -15YOY+17 -183Y+16 -195Y+15 -2010Y+20 -17

3.3 Fundamental Score

Let's check the fundamental score of Anixa Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.291
Price to Book Ratio (EOD)Between0-19.548
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than114.793
Current Ratio (MRQ)Greater than18.446
Debt to Asset Ratio (MRQ)Less than10.127
Debt to Equity Ratio (MRQ)Less than10.135
Return on Equity (MRQ)Greater than0.15-0.136
Return on Assets (MRQ)Greater than0.05-0.128
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Anixa Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.330
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Fundamental data was last updated by Penke on 2025-09-25 06:11:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Anixa earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-431.1%+431.1%
TTM-5Y-72.4%+72.4%
5Y-72.4%10Y-67.6%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--70.7%+70.7%
TTM--161.7%+161.7%
YOY-431.1%-189.8%-241.3%
3Y-224.5%-262.6%+38.1%
5Y-72.4%-338.6%+266.2%
10Y-67.6%-473.1%+405.5%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Anixa is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • -12.8% Return on Assets means thatΒ Anixa generatedΒ $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anixa Biosciences Inc:

  • The MRQ is -12.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-14.9%+2.1%
TTM-14.9%YOY-12.6%-2.2%
TTM-14.9%5Y-12.2%-2.7%
5Y-12.2%10Y-22.3%+10.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-11.9%-0.9%
TTM-14.9%-11.9%-3.0%
YOY-12.6%-11.2%-1.4%
3Y-12.1%-12.0%-0.1%
5Y-12.2%-12.0%-0.2%
10Y-22.3%-14.0%-8.3%
4.3.1.3. Return on Equity

Shows how efficient Anixa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • -13.6% Return on Equity means Anixa generated $-0.14Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anixa Biosciences Inc:

  • The MRQ is -13.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.6%TTM-15.8%+2.2%
TTM-15.8%YOY-13.2%-2.7%
TTM-15.8%5Y-12.7%-3.1%
5Y-12.7%10Y-29.1%+16.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.6%-14.2%+0.6%
TTM-15.8%-14.8%-1.0%
YOY-13.2%-15.3%+2.1%
3Y-12.7%-16.8%+4.1%
5Y-12.7%-17.4%+4.7%
10Y-29.1%-19.8%-9.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anixa Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Anixa is operatingΒ .

  • Measures how much profit Anixa makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-436.1%+436.1%
TTM-5Y-85.7%+85.7%
5Y-85.7%10Y-71.4%-14.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--153.1%+153.1%
TTM--265.6%+265.6%
YOY-436.1%-249.5%-186.6%
3Y-247.4%-248.8%+1.4%
5Y-85.7%-331.9%+246.2%
10Y-71.4%-489.0%+417.6%
4.3.2.2. Operating Ratio

Measures how efficient Anixa is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.909-4.909
TTM-5Y1.019-1.019
5Y1.01910Y0.841+0.179
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.861-1.861
TTM-2.793-2.793
YOY4.9092.852+2.057
3Y2.7363.559-0.823
5Y1.0194.633-3.614
10Y0.8416.269-5.428
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anixa Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anixa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 8.45Β means the company has $8.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 8.446. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.806. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.446TTM8.806-0.360
TTM8.806YOY13.353-4.547
TTM8.8065Y16.520-7.715
5Y16.52010Y10.897+5.624
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.4463.431+5.015
TTM8.8063.644+5.162
YOY13.3534.060+9.293
3Y13.1944.456+8.738
5Y16.5205.742+10.778
10Y10.8976.132+4.765
4.4.3.2. Quick Ratio

Measures if Anixa is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Quick Ratio of 14.79Β means the company can pay off $14.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 14.793. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 15.637. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.793TTM15.637-0.844
TTM15.637YOY24.747-9.110
TTM15.6375Y24.209-8.571
5Y24.20910Y15.697+8.512
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7932.911+11.882
TTM15.6373.133+12.504
YOY24.7473.831+20.916
3Y23.2794.337+18.942
5Y24.2095.697+18.512
10Y15.6976.537+9.160
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anixa Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AnixaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Anixa to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13Β means that Anixa assets areΒ financed with 12.7% credit (debt) and the remaining percentage (100% - 12.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.127. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.123. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.127TTM0.123+0.004
TTM0.123YOY0.081+0.042
TTM0.1235Y0.078+0.044
5Y0.07810Y0.243-0.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1270.344-0.217
TTM0.1230.364-0.241
YOY0.0810.335-0.254
3Y0.0890.344-0.255
5Y0.0780.349-0.271
10Y0.2430.379-0.136
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Anixa is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 13.5% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.135. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.130. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.130+0.005
TTM0.130YOY0.084+0.046
TTM0.1305Y0.082+0.048
5Y0.08210Y0.428-0.346
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1350.401-0.266
TTM0.1300.445-0.315
YOY0.0840.435-0.351
3Y0.0940.471-0.377
5Y0.0820.467-0.385
10Y0.4280.517-0.089
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Anixa generates.

  • Above 15 is considered overpriced butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A PE ratio of -11.15 means the investor is paying $-11.15Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anixa Biosciences Inc:

  • The EOD is -16.291. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.152. Based on the earnings, the company is expensive. -2
  • The TTM is -9.217. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.291MRQ-11.152-5.139
MRQ-11.152TTM-9.217-1.935
TTM-9.217YOY-9.317+0.100
TTM-9.2175Y-10.572+1.355
5Y-10.57210Y-9.954-0.618
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.291-2.840-13.451
MRQ-11.152-2.312-8.840
TTM-9.217-2.654-6.563
YOY-9.317-3.619-5.698
3Y-10.777-3.736-7.041
5Y-10.572-5.803-4.769
10Y-9.954-6.948-3.006
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anixa Biosciences Inc:

  • The EOD is -24.345. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.665. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.807. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-24.345MRQ-16.665-7.679
MRQ-16.665TTM-17.807+1.142
TTM-17.807YOY-14.128-3.680
TTM-17.8075Y-21.215+3.407
5Y-21.21510Y-25.675+4.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-24.345-3.555-20.790
MRQ-16.665-2.911-13.754
TTM-17.807-3.693-14.114
YOY-14.128-4.195-9.933
3Y-19.734-5.149-14.585
5Y-21.215-8.425-12.790
10Y-25.675-9.923-15.752
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Anixa is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 6.54 means the investor is paying $6.54Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anixa Biosciences Inc:

  • The EOD is 9.548. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.536. Based on the equity, the company is overpriced. -1
  • The TTM is 6.127. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD9.548MRQ6.536+3.012
MRQ6.536TTM6.127+0.409
TTM6.127YOY5.098+1.029
TTM6.1275Y5.389+0.738
5Y5.38910Y17.430-12.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.5482.487+7.061
MRQ6.5362.063+4.473
TTM6.1272.237+3.890
YOY5.0982.444+2.654
3Y5.5642.657+2.907
5Y5.3893.804+1.585
10Y17.4304.517+12.913
4.6.2. Total Gains per Share

2.4. Latest News of Anixa Biosciences Inc

Does Anixa Biosciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Anixa Biosciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-10-15
20:04
October 2025 Penny Stocks With Promising PotentialRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anixa Biosciences Inc.

4.8.1. Institutions holding Anixa Biosciences Inc

Institutions are holding 16.506% of the shares of Anixa Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Vanguard Group Inc4.24380.0001139290600
2025-06-30Laird Norton Tyee Trust Co1.88050.2799617235-5000-0.8036
2025-06-30Davidson D A & Co1.87150.014361427200
2025-06-30UBS Group AG1.53950.0003505290-18872-3.6004
2025-06-30Mission Wealth Management, LLC1.12580.0261369517-100000-21.2985
2025-06-30Geode Capital Management, LLC1.04450.000134283625710.7556
2025-06-30Bank of America Corp0.64080.0001210310410.0195
2025-06-30BlackRock Inc0.48590159468-35955-18.3986
2025-06-30State Street Corp0.3671012050000
2025-06-30GSA Capital Partners LLP0.2380.01817810723033.0381
2025-06-30LPL Financial Corp0.22910.0001751871825032.053
2025-06-30Citadel Advisors Llc0.2161070938709380
2025-06-30Northern Trust Corp0.203206668200
2025-06-30Bank of New York Mellon Corp0.1775058271-474-0.8069
2025-06-30CoreCap Advisors, LLC0.14250.00624678720004.4656
2025-06-30Tyler-Stone Wealth Management0.1280.02234201600
2025-06-30Jane Street Group LLC0.12740418001134037.2292
2025-06-30HighTower Advisors, LLC0.11620.00023815025000190.1141
2025-06-30CI Private Wealth LLC0.11390.00013740000
2025-06-30Prosperity Wealth Management Inc0.11120.04463650021006.1047
Total 15.00250.41254924172-25758-0.5%

4.9.2. Funds holding Anixa Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-07-31Vanguard Total Stock Mkt Idx Inv2.76590.0002907815-20026-2.1583
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.95620.0012313835-106823-25.3943
2025-07-31Fidelity Extended Market Index0.50280.0013165043-1358-0.8161
2025-06-30Extended Equity Market Fund K0.21550.001670719-1411-1.9562
2025-08-31iShares Micro-Cap ETF0.21430.02327034300
2025-07-31Fidelity Total Market Index0.1620.000153164-113-0.2121
2025-07-31Fidelity Series Total Market Index0.13080.00024291800
2025-07-31Spartan Extended Market Index Pool F0.11720.00133846613583.6596
2025-06-30Northern Trust Extended Eq Market Idx0.10560.00153467400
2025-06-30NT Ext Equity Mkt Idx Fd - L0.10560.00153467400
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.09420.00163093200
2025-07-31Fidelity Nasdaq Composite Index0.07340.00042410200
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.07320.001624019-60-0.2492
2025-07-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06420.00022107900
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06420.00022107900
2025-07-31Spartan Total Market Index Pool G0.05890.0001193345302.8185
2025-07-31Schwab Total Stock Market Index0.0390.00011278500
2025-07-31Vanguard Balanced Index Inv0.03840.00011259900
2025-07-31Vanguard U.S. Eq Idx Β£ Acc0.03270.00011072900
2025-06-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.02980.00159783145617.4853
Total 5.84390.0381918092-126447-6.6%

5.3. Insider Transactions

Insiders are holding 5.313% of the shares of Anixa Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-07-31Lewis H Titterton JrBUY100003.08
2025-07-30Amit KumarBUY50003.16
2025-07-18Arnold M BaskiesBUY50003.39
2025-07-11Amit KumarBUY50003.15
2025-07-11Lewis H Titterton JrBUY100003.14
2025-06-04Amit KumarBUY100002.85
2025-01-28Arnold M BaskiesBUY50002.82
2025-01-23Lewis H Titterton JrBUY20002.91
2025-01-21Lewis H Titterton JrBUY60002.59
2025-01-17Lewis H Titterton JrBUY100002.57
2025-01-15Amit KumarBUY430002.23
2025-01-15Michael CatelaniBUY92892.15
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-07-31. Currency in USD. All numbers in thousands.

Summary
Total Assets17,651
Total Liabilities2,240
Total Stockholder Equity16,595
 As reported
Total Liabilities 2,240
Total Stockholder Equity+ 16,595
Total Assets = 17,651

Assets

Total Assets17,651
Total Current Assets17,449
Long-term Assets202
Total Current Assets
Cash And Cash Equivalents 1,495
Short-term Investments 14,534
Other Current Assets 1,420
Total Current Assets  (as reported)17,449
Total Current Assets  (calculated)17,449
+/-0
Long-term Assets
Property Plant Equipment 202
Long-term Assets  (as reported)202
Long-term Assets  (calculated)202
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,066
Long-term Liabilities174
Total Stockholder Equity16,595
Total Current Liabilities
Short-term Debt 39
Accounts payable 276
Other Current Liabilities 1,751
Total Current Liabilities  (as reported)2,066
Total Current Liabilities  (calculated)2,066
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt174
Long-term Liabilities  (as reported)174
Long-term Liabilities  (calculated)174
+/-0
Total Stockholder Equity
Common Stock328
Retained Earnings -248,982
Other Stockholders Equity 265,249
Total Stockholder Equity (as reported)16,595
Total Stockholder Equity (calculated)16,595
+/-0
Other
Capital Stock328
Cash and Short Term Investments 16,029
Common Stock Shares Outstanding 32,476
Liabilities and Stockholders Equity 17,651
Net Debt -1,282
Net Invested Capital 16,595
Net Working Capital 15,383
Property Plant and Equipment Gross 202
Short Long Term Debt Total 213



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-07-312025-04-302025-01-312024-10-312024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-12-012017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-311995-07-311995-04-301995-01-311994-10-311994-07-311994-04-301994-01-311993-10-311993-07-311993-04-301993-01-311992-10-311992-07-311992-04-301992-01-311991-10-311991-07-311991-04-301991-01-311990-10-311990-07-311990-04-301990-01-311989-10-311989-07-311989-04-301989-01-311988-10-311988-07-311988-04-301988-01-311987-10-311987-07-311987-04-301987-01-311986-10-311986-07-311986-04-301986-01-311985-10-31
> Total Assets 
3,300
0
0
0
1,500
0
0
0
1,200
0
0
0
2,100
0
0
0
4,200
4,200
4,200
4,200
4,200
4,300
4,200
4,200
4,300
4,500
4,500
4,300
4,400
5,700
6,000
7,900
8,700
7,700
7,200
7,400
6,600
6,000
7,200
9,400
9,700
11,500
15,400
23,400
24,700
23,100
22,500
21,400
20,000
18,300
16,300
15,000
13,300
12,700
11,700
10,500
8,100
8,100
9,740
9,302
6,895
6,302
5,771
7,542
6,562
8,737
7,381
3,575
2,732
2,430
1,826
2,331
2,330
2,131
2,516
2,281
2,316
2,347
2,068
1,756
1,466
1,646
1,696
1,601
1,864
2,048
1,977
1,820
1,870
24,283
21,204
14,624
7,498
6,054
6,008
8,077
9,848
9,711
10,175
8,625
10,046
8,262
8,627
10,169
8,646
8,029
6,794
5,887
5,661
7,522
7,354
5,308
5,440
10,327
10,500
13,399
9,055
13,270
11,133
10,279
9,336
8,647
7,206
6,321
5,628
4,219
7,249
8,415
8,812
8,812,416
7,491
7,361
7,294
6,449
6,470
7,765
6,843
6,294
6,164
5,925
9,362
9,453
14,604
38,498
37,062
36,257
35,238
32,797
32,563
30,412
28,306
27,599
26,578
25,522
25,372
24,355
22,908
21,591
18,906
16,977
17,651
17,65116,97718,90621,59122,90824,35525,37225,52226,57827,59928,30630,41232,56332,79735,23836,25737,06238,49814,6049,4539,3625,9256,1646,2946,8437,7656,4706,4497,2947,3617,4918,812,4168,8128,4157,2494,2195,6286,3217,2068,6479,33610,27911,13313,2709,05513,39910,50010,3275,4405,3087,3547,5225,6615,8876,7948,0298,64610,1698,6278,26210,0468,62510,1759,7119,8488,0776,0086,0547,49814,62421,20424,2831,8701,8201,9772,0481,8641,6011,6961,6461,4661,7562,0682,3472,3162,2812,5162,1312,3302,3311,8262,4302,7323,5757,3818,7376,5627,5425,7716,3026,8959,3029,7408,1008,10010,50011,70012,70013,30015,00016,30018,30020,00021,40022,50023,10024,70023,40015,40011,5009,7009,4007,2006,0006,6007,4007,2007,7008,7007,9006,0005,7004,4004,3004,5004,5004,3004,2004,2004,3004,2004,2004,2004,2004,2000002,1000001,2000001,5000003,300
   > Total Current Assets 
3,000
0
0
0
1,100
0
0
0
700
0
0
0
1,900
0
0
0
4,000
4,000
4,100
4,000
4,000
4,100
4,000
4,100
4,200
4,300
4,300
4,100
4,200
5,500
5,800
7,600
8,400
7,400
6,800
7,100
6,300
5,700
6,900
8,800
9,000
10,300
14,000
21,500
22,600
21,000
20,600
19,600
18,200
16,700
14,800
13,700
9,000
8,600
7,700
7,200
7,500
7,600
9,310
8,952
3,655
3,121
2,641
4,549
3,580
5,753
4,445
3,480
2,654
2,363
1,768
2,280
2,285
2,089
2,476
2,241
2,272
2,305
2,029
1,720
1,434
1,611
1,566
1,364
1,623
1,597
1,524
1,368
1,416
1,553
1,622
2,316
2,257
2,831
2,386
2,179
2,396
2,122
1,974
1,528
1,235
1,088
1,785
3,644
3,120
2,610
1,788
1,145
922
1,780
1,326
1,029
1,234
3,367
3,630
6,435
6,322
10,571
8,523
7,754
6,896
6,187
4,801
4,006
3,400
2,069
5,192
6,446
7,014
7,013,940
5,775
5,721
5,720
5,538
6,236
7,494
6,628
6,093
5,869
5,657
9,264
9,369
14,564
38,472
37,052
36,003
34,994
32,563
32,340
30,200
28,105
27,410
26,400
25,356
25,219
24,214
22,670
21,362
18,686
16,766
17,449
17,44916,76618,68621,36222,67024,21425,21925,35626,40027,41028,10530,20032,34032,56334,99436,00337,05238,47214,5649,3699,2645,6575,8696,0936,6287,4946,2365,5385,7205,7215,7757,013,9407,0146,4465,1922,0693,4004,0064,8016,1876,8967,7548,52310,5716,3226,4353,6303,3671,2341,0291,3261,7809221,1451,7882,6103,1203,6441,7851,0881,2351,5281,9742,1222,3962,1792,3862,8312,2572,3161,6221,5531,4161,3681,5241,5971,6231,3641,5661,6111,4341,7202,0292,3052,2722,2412,4762,0892,2852,2801,7682,3632,6543,4804,4455,7533,5804,5492,6413,1213,6558,9529,3107,6007,5007,2007,7008,6009,00013,70014,80016,70018,20019,60020,60021,00022,60021,50014,00010,3009,0008,8006,9005,7006,3007,1006,8007,4008,4007,6005,8005,5004,2004,1004,3004,3004,2004,1004,0004,1004,0004,0004,1004,0004,0000001,9000007000001,1000003,000
       Cash And Cash Equivalents 
2,800
0
0
0
1,000
0
0
0
700
0
0
0
1,700
0
0
0
2,200
2,500
1,700
2,200
2,100
2,100
3,000
2,100
4,100
4,300
4,300
4,100
4,100
5,400
5,800
7,600
8,300
7,400
6,800
7,000
6,200
5,700
6,900
8,700
8,900
10,200
13,900
21,400
22,200
19,500
18,500
15,800
12,300
11,200
8,000
6,100
5,400
4,400
3,700
2,300
1,600
2,100
3,589
2,621
1,134
703
158
2,016
1,317
3,455
2,142
1,302
855
603
408
1,057
1,024
868
1,243
1,040
1,003
1,012
641
582
507
809
732
611
1,282
828
766
653
669
794
764
458
479
1,716
1,291
321
1,451
1,197
1,075
1,409
1,094
979
347
551
774
463
131
102
340
1,713
1,274
982
898
776
618
3,652
3,361
7,810
6,080
5,161
4,369
3,981
2,612
2,049
2,488
1,400
2,877
1,834
3,339
3,339,374
2,847
4,172
2,591
3,056
4,153
3,822
4,397
3,492
2,822
2,888
5,928
6,417
11,983
27,703
27,222
29,128
29,781
27,732
24,254
12,360
9,790
5,620
3,198
915
998
995
1,225
1,271
1,053
1,910
1,495
1,4951,9101,0531,2711,2259959989153,1985,6209,79012,36024,25427,73229,78129,12827,22227,70311,9836,4175,9282,8882,8223,4924,3973,8224,1533,0562,5914,1722,8473,339,3743,3391,8342,8771,4002,4882,0492,6123,9814,3695,1616,0807,8103,3613,6526187768989821,2741,7133401021314637745513479791,0941,4091,0751,1971,4513211,2911,7164794587647946696537668281,2826117328095075826411,0121,0031,0401,2438681,0241,0574086038551,3022,1423,4551,3172,0161587031,1342,6213,5892,1001,6002,3003,7004,4005,4006,1008,00011,20012,30015,80018,50019,50022,20021,40013,90010,2008,9008,7006,9005,7006,2007,0006,8007,4008,3007,6005,8005,4004,1004,1004,3004,3004,1002,1003,0002,1002,1002,2001,7002,5002,2000001,7000007000001,0000002,800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
500
0
97
97
97
97
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
398
401
403
398
398
38
425
425
400
400
441
441
1,440
1,442
750
750
1,650
750
750
750
0
0
0
1,349
2,999
2,249
2,050
1,550
950
500
500
0
0
0
2,450
2,050
2,550
2,500
2,650
2,400
2,400
2,400
2,150
2,150
1,900
750
600
2,250
4,251
3,500
3,500,000
2,650
1,250
2,750
2,000
1,750
2,750
2,100
2,350
2,870
2,620
3,140
2,640
2,000
10,399
9,400
6,600
4,749
4,499
7,410
17,327
17,912
21,356
22,336
22,929
22,800
22,244
19,520
18,653
16,202
13,687
14,534
14,53413,68716,20218,65319,52022,24422,80022,92922,33621,35617,91217,3277,4104,4994,7496,6009,40010,3992,0002,6403,1402,6202,8702,3502,1002,7501,7502,0002,7501,2502,6503,500,0003,5004,2512,2506007501,9002,1502,1502,4002,4002,4002,6502,5002,5502,0502,4500005005009501,5502,0502,2492,9991,3490007507507501,6507507501,4421,4404414414004004254253839839840340139839600000000000000009797979705005000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
478
595
561
708
694
536
562
507
525
401
463
215
177
169
140
145
150
148
288
99
173
62
30
68
37
10
69
60
60
120
60
191
207
103
112
106
12
1
1
8
5
0
-141
0
0
0
0
0
0
0
0
0
0
175
175
828
133
400
45
0
0
0
0
0
0
0
0
0
221
0
0
0
0
0
307
0
797
1
67
22
32
6
2
0
0
0
0
0
0
0
46
147
256
334
270
391
218
410
173
0
0
0
000173410218391270334256147460000000263222671797030700000221000000000454001338281751750000000000-1410581112106112103207191601206060691037683062173992881481501451401691772154634015255075625366947085615954780000000000000000000000000000000000000000001,8000000000000000000
       Inventory 
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
3,000
2,800
3,600
4,500
4,400
4,360
4,868
1,769
1,834
1,761
1,620
1,589
1,497
1,601
1,517
1,296
1,170
1,032
1,028
1,045
1,036
1,064
1,033
999
977
877
555
385
330
308
281
261
243
231
214
192
225
196
185
178
177
176
138
133
110
93
59
52
47
32
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-46
0
0
0
0
0
0
0
0
0
0
0
00000000000-460000000000000000000000000000000000000000000003332475259931101331381761771781851962251922142312432612813083303855558779779991,0331,0641,0361,0451,0281,0321,1701,2961,5171,6011,4971,5891,6201,7611,8341,7694,8684,3604,4004,5003,6002,8003,00001,80000000000000000000000000000000000000000000000000000100
       Other Current Assets 
100
0
0
0
100
0
0
0
0
0
0
0
200
0
0
0
0
1,500
2,400
1,800
1,900
2,000
1,000
2,000
100
0
0
0
100
100
0
0
100
0
0
100
100
0
0
100
100
100
100
100
400
1,500
2,100
3,800
5,900
5,500
6,800
5,800
3,600
1,200
1,200
800
900
1,100
1,264
888
60
23
14
219
137
239
194
137
103
128
113
17
48
45
23
18
122
27
17
12
481
38
60
36
32
32
42
41
35
33
30
26
54
77
63
58
124
65
48
56
89
62
57
61
97
97
107
93
82
67
104
95
161
141
134
101
61
66
43
194
127
56
39
113
162
137
129
281
175
0
278
596
757
175
667
249
259
185
309
233
380
312
1,163
738
860
552
928
664
676
467
256
178
532
1,242
1,030
757
1,515
1,265
1,431
1,169
1,420
1,4201,1691,4311,2651,5157571,0301,2425321782564676766649285528607381,163312380233309185259249667175757596278017528112913716211339561271944366611011341411619510467829310797976157628956486512458637754263033354142323236603848112172712218234548171131281031371942391372191423608881,2641,1009008001,2001,2003,6005,8006,8005,5005,9003,8002,1001,5004001001001001001000010010000100001001000001002,0001,0002,0001,9001,8002,4001,50000002000000000100000100
   > Long-term Assets 
300
0
0
0
400
0
0
0
500
0
0
0
200
0
0
0
200
200
100
200
200
200
200
100
100
200
200
200
200
200
200
300
300
300
400
300
300
300
300
600
700
1,200
1,400
1,900
2,100
2,100
1,900
1,800
1,800
1,600
1,500
1,300
4,300
4,100
4,000
3,300
600
500
430
350
3,239
3,181
3,130
2,993
2,983
2,984
2,936
96
77
67
58
52
45
41
40
40
44
42
39
35
32
36
130
238
241
450
453
452
455
22,729
19,582
12,308
5,241
3,223
3,621
5,898
7,452
7,589
8,202
7,096
0
7,174
6,842
6,524
5,525
5,420
5,006
4,742
4,739
5,742
6,028
4,278
4,206
6,960
6,870
6,964
2,734
2,699
2,610
2,525
2,440
2,461
2,404
2,316
2,228
2,150
2,058
1,969
1,798
0
1,715
1,640
1,574
910
234
272
215
201
295
268
98
84
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
229
220
211
202
20221122022923814115316617818920121222323424425410264084982682952012152722349101,5741,6401,71501,7981,9692,0582,1502,2282,3162,4042,4612,4402,5252,6102,6992,7346,9646,8706,9604,2064,2786,0285,7424,7394,7425,0065,4205,5256,5246,8427,17407,0968,2027,5897,4525,8983,6213,2235,24112,30819,58222,7294554524534502412381303632353942444040414552586777962,9362,9842,9832,9933,1303,1813,2393504305006003,3004,0004,1004,3001,3001,5001,6001,8001,8001,9002,1002,1001,9001,4001,200700600300300300300400300300300200200200200200200100100200200200200100200200000200000500000400000300
       Property Plant Equipment 
300
0
0
0
300
0
0
0
300
0
0
0
200
0
0
0
100
100
100
100
100
100
100
100
-500
100
-500
100
100
100
100
100
200
200
200
200
200
200
200
200
200
200
500
500
800
900
900
900
900
900
900
800
800
700
700
600
500
500
403
325
270
212
162
129
119
121
103
84
72
61
53
46
39
36
35
34
38
37
33
30
27
31
28
26
23
22
25
24
27
31
33
31
30
27
24
24
21
19
17
15
15
19
19
18
16
15
14
12
10
11
8
9
8
8
8
10
12
59
51
47
43
146
171
163
157
160
149
141
53
52,701
51
57
72
73
67
230
215
201
295
268
68
54
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
229
220
211
202
2022112202292381411531661781892012122232342442541026405468268295201215230677372575152,701531411491601571631711464347515912108889811101214151618191915151719212424273031333127242522232628312730333738343536394653617284103121119129162212270325403500500600700700800800900900900900900900800500500200200200200200200200200200200100100100100100-500100-500100100100100100100100100000200000300000300000300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,506
5,510
5,405
4,992
4,730
4,728
5,731
6,021
4,269
4,197
3,986
3,977
4,151
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000004,1513,9773,9864,1974,2696,0215,7314,7284,7304,9925,4055,5106,5060000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,966
2,884
2,803
2,722
2,640
2,559
2,478
2,396
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,664
1,583
1,502
838
168
42
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000421688381,5021,5831,66401,7461,8271,9081,9902,0712,1522,2342,3152,3962,4782,5592,6402,7222,8032,8842,96600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
26
25
2,970
2,969
2,968
2,864
2,863
2,863
2,833
11
6
6
5
5
6
6
6
6
6
5
6
5
5
5
102
211
218
428
428
428
427
22,699
19,549
12,277
5,211
3,196
3,598
5,874
7,431
7,570
8,184
7,082
8,796
7,155
6,823
6,507
5,510
5,405
4,992
4,730
4,729
5,731
6,021
4,270
4,197
6,952
6,862
6,954
2,721
2,640
2,559
2,478
2,397
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,665
1,583
1,503
838
0
0
0
0
0
0
30
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000084300000008381,5031,5831,66501,7461,8271,9081,9902,0712,1522,2342,3152,3972,4782,5592,6402,7216,9546,8626,9524,1974,2706,0215,7314,7294,7304,9925,4055,5106,5076,8237,1558,7967,0828,1847,5707,4315,8743,5983,1965,21112,27719,54922,69942742842842821821110255565666665566112,8332,8632,8632,8642,9682,9692,970252627000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
100
100
100
200
200
200
300
300
400
300
500
600
400
300
200
300
300
200
300
500
500
800
1,900
1,500
1,300
1,500
1,200
1,300
1,100
1,400
1,400
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
462
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
5,587
5,483
6,594
5,768
5,680
5,456
5,212
5,396
5,391
5,389
5,492
5,450
5,583
5,552
7,927
7,588
7,291
7,133
6,780
6,855
8,846
8,800
8,545
8,760
15,997
15,346
13,250
5,046
5,013
4,143
4,282
4,282
5,056
4,646
4,603
4,641
8,037
3,660
2,927
889
8,812,416
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,166
1,103
1,224
1,189
1,525
1,443
1,208
1,491
1,996
1,391
1,656
2,212
1,394
1,686
1,993
2,151
1,768
1,774
2,217
2,703
2,193
2,071
2,240
2,2402,0712,1932,7032,2171,7741,7682,1511,9931,6861,3942,2121,6561,3911,9961,4911,2081,4431,5251,1891,2241,1031,1661,4811,4441,5961,3271,2651,1291,3401,0878,812,4168892,9273,6608,0374,6414,6034,6465,0564,2824,2824,1435,0135,04613,25015,34615,9978,7608,5458,8008,8466,8556,7807,1337,2917,5887,9275,5525,5835,4505,4925,3895,3915,3965,2125,4565,6805,7686,5945,4835,5876793203283675822923724723482702934224433604083833423904214624143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,4001,4001,1001,3001,2001,5001,3001,5001,900800500500300200300300200300400600500300400300300200200200100100100100100100100100100000100000100000200000200
   > Total Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
200
100
200
200
200
200
300
200
400
300
400
600
400
300
200
300
300
200
200
400
600
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,500
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
462
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
587
483
1,594
768
680
456
212
396
391
389
492
450
583
552
2,927
2,105
2,055
2,133
1,780
1,822
3,439
3,301
3,095
3,212
11,548
10,682
8,357
1,810
1,667
689
712
594
1,244
707
532
469
3,724
3,660
2,927
889
889,493
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,126
1,077
1,213
1,189
1,525
1,443
1,208
1,271
1,787
1,189
1,469
2,037
1,232
1,537
1,857
2,028
1,660
1,681
2,004
2,500
1,999
1,887
2,066
2,0661,8871,9992,5002,0041,6811,6602,0281,8571,5371,2322,0371,4691,1891,7871,2711,2081,4431,5251,1891,2131,0771,1261,4811,4441,5961,3271,2651,1291,3401,087889,4938892,9273,6603,7244695327071,2445947126891,6671,8108,35710,68211,5483,2123,0953,3013,4391,8221,7802,1332,0552,1052,9275525834504923893913962124566807681,5944835876793203283675822923724723482702934224433604083833423904214624143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,5001,4001,1001,3001,2001,5001,4001,5002,000700600400200200300300200300400600400300400200300200200200200100200100100100100100100000100000100000200000200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582
610
691
957
5,668
5,000
5,000
0
0
0
0
0
0
0
0
0
3,000
3,000
2,000
0
0
0
0
0
0
0
0
0
0
107
111
116
110
82
52
21
78
82
78
44
92
94
98
102
104
108
112
24
29
36
37
39
39373629241121081041029894924478827821528211011611110700000000002,0003,0003,0000000000005,0005,0005,6689576916105820000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
100
100
100
200
200
200
300
200
400
300
400
600
400
300
200
200
300
200
200
400
500
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,400
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
815
816
548
410
341
379
411
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
403
424
308
385
470
294
104
326
315
304
390
356
431
456
278
375
449
559
463
305
489
534
516
527
492
458
529
540
578
389
425
162
560
418
445
373
541
448
445
480
0
417
452
419
582
613
718
568
586
367
171
339
232
512
438
208
136
504
93
227
265
110
195
94
206
364
215
302
525
600
284
276
276284600525302215364206941951102652279350413620843851223233917136758656871861358241945241704804454485413734454185601624253895785405294584925275165344893054635594493752784564313563903043153261042944703853084244033472441993185332533134042712312523984033233743343173533804113793414105488168159401,0451,0362,1671,9491,7001,5001,3001,2001,2001,4001,4001,1001,3001,2001,5001,4001,5002,00070050040020020030020020030040060040030040020030020020020010010010010010010010010000000000000000000
       Other Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
0
0
0
0
0
100
0
100
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
100
0
0
0
0
0
0
0
0
0
100
200
100
300
300
300
126
168
301
224
206
220
38
57
41
53
35
51
42
37
25
49
34
37
40
24
41
39
77
68
59
39
49
49
129
76
332
184
59
56
69
210
161
108
70
76
86
103
94
152
96
75
86
162
140
130
331
1,762
1,580
1,391
1,497
4,201
4,037
2,828
1,269
1,090
300
287
432
684
289
87
96
183
212
482
409
0
670
888
710
683
714
878
876
895
652
794
758
846
932
953
979
1,056
1,201
1,018
1,198
1,680
1,028
1,244
1,661
1,718
1,188
1,354
1,654
1,946
1,363
1,566
1,751
1,7511,5661,3631,9461,6541,3541,1881,7181,6611,2441,0281,6801,1981,0181,2011,056979953932846758794652895876878714683710888670040948221218396872896844322873001,0901,2692,8284,0374,2011,4971,3911,5801,7623311301401628675961529410386767010816121069565918433276129494939596877394124403734492537425135534157382202062243011681263003003001002001000000000001000000100000000000000100010000000100000100000100000200000200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
-100
100
-100
200
200
200
300
100
400
300
100
600
400
300
200
200
300
200
100
100
-100
100
-100
1,500
-100
1,500
1,200
1,300
1,100
1,400
-100
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
2,982
2,358
4,057
1,494
341
0
411
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
0
5,000
5,000
5,000
5,483
5,236
5,000
5,000
5,032
5,408
5,499
5,451
5,549
4,449
4,664
4,893
3,236
3,345
3,454
3,570
3,688
3,812
3,939
4,071
4,172
4,313
3,448
2,445
480
0
409,169
452
419
582
613
718
568
586
41
26
11
288
553
464
218
220
209
202
187
175
162
149
136
123
108
93
213
203
194
184
174
17418419420321393108123136149162175187202209220218464553288112641586568718613582419452409,16904802,4453,4484,3134,1724,0713,9393,8123,6883,5703,4543,3453,2364,8934,6644,4495,5495,4515,4995,4085,0325,0005,0005,2365,4835,0005,0005,00005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,00034724419931853325331340427123125239840332337433431735338041103411,4944,0572,3582,9829401,0451,0362,1671,9491,7001,5001,3001,2001,200-1001,4001,1001,3001,2001,500-1001,500-100100-100100100200300200200300400600100300400100300200200200-100100-10010010010010010000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
408
454
451
549
1,512
1,627
1,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000001,7561,6271,51254945145440832000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
46
0
0
2,937
3,037
3,136
3,236
3,346
3,454
3,569
3,688
3,812
3,939
4,071
4,172
4,313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000004,3134,1724,0713,9393,8123,6883,5693,4543,3463,2363,1363,0372,9370046000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
3,100
0
0
0
1,300
0
0
0
1,100
0
0
0
2,000
0
0
0
4,100
4,100
4,100
4,100
4,100
4,200
4,100
4,100
4,200
4,300
4,300
4,100
4,100
5,400
5,600
7,600
8,200
7,100
6,800
7,100
6,400
5,700
6,900
9,200
9,400
11,000
14,900
22,600
22,800
21,600
21,200
19,900
18,800
17,000
15,200
13,600
11,900
11,300
10,400
8,900
6,300
6,100
7,664
6,967
5,558
5,033
4,624
4,340
4,167
4,623
5,846
3,182
2,317
1,969
1,405
1,941
1,988
1,747
2,108
1,920
1,873
1,925
1,775
1,486
1,118
1,174
1,325
1,309
1,282
1,680
1,649
1,500
1,191
18,696
15,720
8,030
1,730
374
552
2,865
4,452
4,320
4,786
3,132
4,596
2,679
3,075
2,241
1,058
738
-339
-893
-1,194
-1,324
-1,446
-3,238
-3,321
-5,669
-4,846
150
4,010
8,258
6,990
5,998
5,054
3,591
2,560
1,718
987
-3,819
3,589
5,488
7,923
0
6,436
6,066
6,326
5,435
5,479
6,543
5,799
5,235
5,445
5,287
8,618
8,761
13,600
37,614
36,467
35,437
33,963
32,171
31,701
29,047
27,791
26,811
25,520
24,337
24,605
23,623
21,771
19,998
17,852
16,068
16,595
16,59516,06817,85219,99821,77123,62324,60524,33725,52026,81127,79129,04731,70132,17133,96335,43736,46737,61413,6008,7618,6185,2875,4455,2355,7996,5435,4795,4356,3266,0666,43607,9235,4883,589-3,8199871,7182,5603,5915,0545,9986,9908,2584,010150-4,846-5,669-3,321-3,238-1,446-1,324-1,194-893-3397381,0582,2413,0752,6794,5963,1324,7864,3204,4522,8655523741,7308,03015,72018,6961,1911,5001,6491,6801,2821,3091,3251,1741,1181,4861,7751,9251,8731,9202,1081,7471,9881,9411,4051,9692,3173,1825,8464,6234,1674,3404,6245,0335,5586,9677,6646,1006,3008,90010,40011,30011,90013,60015,20017,00018,80019,90021,20021,60022,80022,60014,90011,0009,4009,2006,9005,7006,4007,1006,8007,1008,2007,6005,6005,4004,1004,1004,3004,3004,2004,1004,1004,2004,1004,1004,1004,1004,1000002,0000001,1000001,3000003,100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
600
600
600
629
631
631
638
645
656
665
673
680
688
703
724
745
788
802
813
836
846
855
869
885
905
920
938
952
968
993
1,019
1,035
1,049
1,069
1,286
1,300
1,311
1,325
1,354
1,390
1,418
1,446
1,460
1,484
1,507
1,537
1,582
1,686
1,722
1,761
1,805
1,815
1,842
1,850
1,851
1,999
2,062
2,093
2,105
2,194
2,368
2,197
2,197
2,189
87
87
87
87
87
88
88
117
151
166
0
166
169
187
189
195
200
202
203
208
215
237
242
262
314
299
301
301
302
307
309
309
310
310
311
318
320
321
322
322
322
328
3283223223223213203183113103103093093073023013012993142622422372152082032022001951891871691660166151117888887878787872,1892,1972,1972,3682,1942,1052,0932,0621,9991,8511,8501,8421,8151,8051,7611,7221,6861,5821,5371,5071,4841,4601,4461,4181,3901,3541,3251,3111,3001,2861,0691,0491,0351,0199939689529389209058858698558468368138027887457247036886806736656566456386316316296006006000000000000000000000000000000000000000000000000000000000
   Retained Earnings -248,982-246,724-243,934-240,750-237,867-234,590-231,451-228,196-225,506-222,995-220,707-218,385-214,909-212,163-208,619-204,790-200,777-196,443-194,044-191,836-189,612-187,050-184,410-181,817-179,730-177,590-175,052-170,170-164,868-159,391-158,0120-156,174-154,388-152,594-152,754-151,165-150,118-149,014-147,742-146,149-144,856-143,254-141,018-144,770-141,616-142,027-138,778-135,163-132,237-129,655-127,178-125,083-123,223-122,594-121,717-120,831-118,039-116,266-114,979-113,452-112,326-111,055-109,784-108,277-95,693-94,507-93,163-91,788-91,223-90,493-88,652-85,967-84,769-83,714-82,282-80,509-78,707-76,560-74,147-72,908-71,762-70,643-69,463-68,456-67,634-66,600-65,905-65,096-64,407-63,756-62,786-61,981-60,767-57,738-58,636-58,696-57,989-57,042-56,254-55,124-53,715-52,741-51,500-50,200-46,600-44,700-43,100-41,700-40,000-38,300-36,500-34,500-33,200-31,700-30,100-28,800-26,800-25,300-24,300-23,300-22,400-21,700-21,000-20,300-19,700-18,800-18,000-16,900-15,500-15,500-14,100-14,100-12,300-12,300-12,300-12,300-11,000-11,000-11,000-11,000-10,200-10,200-10,200-9,900000-8,800000-7,500000-6,100000-4,300
   Accumulated Other Comprehensive Income 
-100
0
0
0
-100
0
0
0
-200
0
0
0
-300
0
0
0
-400
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-600
-600
-600
-600
-600
-600
-600
-600
-700
-700
-700
-700
-700
-800
-800
-900
-900
-1,000
-1,100
-1,100
-1,200
-1,300
-1,400
-1,400
-1,500
-1,600
-1,600
-1,700
-1,760
-1,776
-1,838
-1,838
-1,838
-1,838
-2,004
-2,004
-2,004
-2,004
-2,051
-2,051
-2,051
-2,051
-2,084
-2,084
-2,084
-2,084
-2,101
-2,101
-2,101
-2,101
-2,116
-2,116
-2,116
-2,116
-2,131
-2,131
-2,131
-2,131
-2,141
1,071
-2,079
-10,345
-17,155
-13,390
-12,986
-10,702
-2,162
158
776
-308
1,000
-211
-473
-789
-2,178
-105
-518
-779
-654
349
639
-1,113
-5,000
-211
-220
-46
-350
-2
-6
-10
-14
-17
-27
-39
-102
-57
-68
-79
-36
0
-40
-43
-48
-54
-60
-72
-87
-95
0
-124
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000-1240-95-87-72-60-54-48-43-400-36-79-68-57-102-39-27-17-14-10-6-2-350-46-220-211-5,000-1,113639349-654-779-518-105-2,178-789-473-2111,000-308776158-2,162-10,702-12,986-13,390-17,155-10,345-2,0791,071-2,141-2,131-2,131-2,131-2,131-2,116-2,116-2,116-2,116-2,101-2,101-2,101-2,101-2,084-2,084-2,084-2,084-2,051-2,051-2,051-2,051-2,004-2,004-2,004-2,004-1,838-1,838-1,838-1,838-1,776-1,760-1,700-1,600-1,600-1,500-1,400-1,400-1,300-1,200-1,100-1,100-1,000-900-900-800-800-700-700-700-700-700-600-600-600-600-600-600-600-600-500-500-500-500-500-500-500-500-500-500-500-500-500-400000-300000-200000-100000-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,348
125,127
125,755
125,958
126,267
127,693
128,655
130,571
133,050
134,750
136,214
140,207
144,444
146,232
146,728
147,705
150,753
151,101
151,232
151,472
151,734
152,051
148,848
156,066
159,725
163,931
0
164,282
165,289
171,007
175,416
180,337
183,933
185,327
186,849
189,646
192,122
197,993
200,354
207,382
233,742
236,944
0
0
244,032
246,303
247,123
248,189
249,496
250,716
0
0
0
0
0
0
0
0
00000000250,716249,496248,189247,123246,303244,03200236,944233,742207,382200,354197,993192,122189,646186,849185,327183,933180,337175,416171,007165,289164,2820163,931159,725156,066148,848152,051151,734151,472151,232151,101150,753147,705146,728146,232144,444140,207136,214134,750133,050130,571128,655127,693126,267125,958125,755125,127124,3480000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
7,500
0
0
0
7,500
0
0
0
8,800
0
0
0
11,100
0
0
0
14,400
14,800
14,800
14,800
15,600
15,700
15,600
15,600
17,000
17,100
17,100
16,900
18,700
20,000
21,700
23,700
25,700
25,700
26,200
27,400
27,300
27,300
29,300
32,300
33,400
36,000
40,900
50,200
52,400
52,600
53,800
54,100
54,400
54,600
54,700
54,900
55,000
55,800
56,600
54,900
55,900
57,000
59,776
60,051
60,051
60,649
61,022
61,673
62,197
62,586
62,904
63,261
65,647
64,030
64,416
65,560
66,282
66,839
67,871
68,709
69,474
70,519
71,532
72,343
73,106
74,383
76,932
79,049
80,798
82,944
84,328
85,220
86,089
104,991
106,993
108,286
109,349
105,573
106,655
107,842
111,284
112,485
113,581
114,259
0
116,286
118,127
119,348
120,127
120,755
120,958
121,267
122,693
123,655
125,571
128,050
134,750
131,214
135,207
139,444
148,677
146,728
147,705
150,753
151,101
151,232
151,472
151,734
152,051
148,906
156,066
159,725
163,931
0
164,282
165,289
171,007
175,416
180,337
183,933
185,327
186,849
189,646
192,122
197,993
200,354
207,382
233,742
236,944
239,927
242,281
244,032
246,303
247,123
248,189
249,496
250,716
252,222
255,738
257,893
259,317
260,426
261,464
262,470
265,249
265,249262,470261,464260,426259,317257,893255,738252,222250,716249,496248,189247,123246,303244,032242,281239,927236,944233,742207,382200,354197,993192,122189,646186,849185,327183,933180,337175,416171,007165,289164,2820163,931159,725156,066148,906152,051151,734151,472151,232151,101150,753147,705146,728148,677139,444135,207131,214134,750128,050125,571123,655122,693121,267120,958120,755120,127119,348118,127116,2860114,259113,581112,485111,284107,842106,655105,573109,349108,286106,993104,99186,08985,22084,32882,94480,79879,04976,93274,38373,10672,34371,53270,51969,47468,70967,87166,83966,28265,56064,41664,03065,64763,26162,90462,58662,19761,67361,02260,64960,05160,05159,77657,00055,90054,90056,60055,80055,00054,90054,70054,60054,40054,10053,80052,60052,40050,20040,90036,00033,40032,30029,30027,30027,30027,40026,20025,70025,70023,70021,70020,00018,70016,90017,10017,10017,00015,60015,60015,70015,60014,80014,80014,80014,40000011,1000008,8000007,5000007,500



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-10-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-37
Gross Profit-37-37
 
Operating Income (+$)
Gross Profit-37
Operating Expense-13,831
Operating Income-13,831-13,868
 
Operating Expense (+$)
Research Development6,396
Selling General Administrative7,435
Selling And Marketing Expenses0
Operating Expense13,83113,831
 
Net Interest Income (+$)
Interest Income1,133
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,133
 
Pretax Income (+$)
Operating Income-13,831
Net Interest Income1,133
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,698-14,964
EBIT - interestExpense = -12,698
-12,410
-12,554
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-12,698-12,698
Earnings Before Interest and Taxes (EBITDA)-12,661
 
After tax Income (+$)
Income Before Tax-12,698
Tax Provision-0
Net Income From Continuing Ops-12,698-12,698
Net Income-12,554
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,831
Total Other Income/Expenses Net1,133-1,133
 

Technical Analysis of Anixa
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anixa. The general trend of Anixa is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anixa's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Anixa Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anixa Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.13.

The bearish price targets are: 4.2 > 4.1 > 4.0954.

Know someone who trades $ANIX? Share this with them.πŸ‘‡

Anixa Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anixa Biosciences Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anixa Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnixa Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anixa Biosciences Inc. The current adx is .

Anixa Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Relative Strength Index (RSI) ChartAnixa Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Stochastic Oscillator ChartAnixa Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Commodity Channel Index (CCI) ChartAnixa Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAnixa Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Williams %R ChartAnixa Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Average True Range (ATR) ChartAnixa Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily On-Balance Volume (OBV) ChartAnixa Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Money Flow Index (MFI) ChartAnixa Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anixa Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-10-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Anixa Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern
2025-10-09Three White Soldiers Candle Pattern

6.4. Technical Score

Let's check the technical score of Anixa Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose4.330
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Anixa with someone you think should read this too:
  • Are you bullish or bearish on Anixa? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anixa? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anixa Biosciences Inc

I send you an email if I find something interesting about Anixa Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Anixa Biosciences Inc.

Receive notifications about Anixa Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.